Evidence map›Paper›PMID 25113067›Full record

Observational studyJournal of nephrology2015

Parathyroid hormone may be an early predictor of low serum hemoglobin concentration in patients with not advanced stages of chronic kidney disease.

Domenico Russo, Luigi Morrone, Biagio Di Iorio, Michele Andreucci, Maria Grazia De Gregorio, Carmela Errichiello, Luigi Russo, Francesco Locatelli

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Journal of nephrology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Treatment of hyperphosphatemia: the dangers of high PTH levels.Pediatric nephrology (Berlin, Germany) · 2020
    Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Vitamin D and anemia: insights into an emerging association.Current opinion in endocrinology, diabetes, and obesity · 2015
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Domenico RussoDepartment of Nephrology, University of Naples "FEDERICO II", Via S. Pansini, 5, 80131, Naples, Italy. domenicorusso51@hotmail.com.
Luigi MorroneDepartment of Nephrology, "G. RUMMO" Hospital, Benevento, Italy. lfmorrone@gmail.com.
Biagio Di IorioDepartment of Nephrology, "A. LANDOLFI" Hospital, Solofra, Avellino, Italy.
Michele AndreucciDepartment of Health Sciences, University of Catanzaro, Catanzaro, Italy.
Maria Grazia De GregorioDepartment of Nephrology, University of Naples "FEDERICO II", Via S. Pansini, 5, 80131, Naples, Italy.
Carmela ErrichielloDepartment of Nephrology, University of Naples "FEDERICO II", Via S. Pansini, 5, 80131, Naples, Italy.
Luigi RussoDepartment of Nephrology, University of Naples "FEDERICO II", Via S. Pansini, 5, 80131, Naples, Italy.
Francesco LocatelliDepartment of Nephrology, Alessandro Manzoni Hospital, Lecco, Italy.
University of Naples Federico II · ITAlessandro Manzoni Hospital · ITAzienda Ospedaliera G.Rummo · ITOspedale Civile di Voghera · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParathyroid hormone (PTH) has been associated with anemia only in dialysis patients with severe hyperparathyroidism. Whether an association between PTH and hemoglobin also exists in patients with chronic kidney disease not on dialysis (CKD-patients) is still unclear. In this study we evaluated the association between PTH and hemoglobin in CKD-patients without severe secondary hyperparathyroidism.

methodsHospitalized patients and outpatients (N = 979) were retrospectively evaluated and categorized according to PTH quartile and serum hemoglobin (<12.0, <11.0, <10.0 g/dl). Gender, diabetes, glomerular filtration rate (GFR), hemoglobin, PTH, markers of mineral metabolism, inflammation, iron status and nutrition were variables of adjustment in univariate and multivariate analysis.

resultsAn inverse association (p = 0.001) was observed between PTH and hemoglobin in patients as a whole, in diabetics, and in patients with GFR ≤60 ml/min. PTH was the single predictor of low hemoglobin in patients as a whole (unstandardized beta -2.12; p = 0.005), in diabetics (unstandardized beta -8.86; p = 0.007) and in patients with GFR ≤60 ml/min (unstandardized beta -2.52; p = 0.006). For each increase of quartile of PTH the risk of having hemoglobin level <10.0 mg/dl was more than doubled [hazard ratio (HR) 2.79, 95% confidence interval (CI) 2.00-3.88; p = 0.001]. The receiver operating characteristic curve showed that PTH ≥122 pg/ml had 67% sensitivity and 75% specificity in predicting hemoglobin level <10.0 g/dl with area under the curve of 0.758 (95% CI 0.73-0.78).

conclusionsThis study shows a significant inverse association between PTH and hemoglobin levels across the whole spectrum of non-dialysis CKD and a doubled risk of having serum hemoglobin <10.0 mg/dl in the absence of severely deranged PTH concentration. These findings may have clinical relevance in ascertaining the cause of unexplained low hemoglobin levels in CKD-patients.

Indexed as

AdultAgedArea Under CurveFemaleGlomerular Filtration RateHemoglobinsHumansMaleMiddle AgedParathyroid HormonePredictive Value of TestsRenal Insufficiency, ChronicRetrospective StudiesROC CurveSeverity of Illness IndexHemoglobinsParathyroid HormoneAnemiaChronic kidney diseaseHemoglobinParathyroid hormone

Identifiers

PMID25113067
PMCPMC4605967
OpenAlexW2053923486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.